CN103772483A - (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 - Google Patents
(3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 Download PDFInfo
- Publication number
- CN103772483A CN103772483A CN201310308801.XA CN201310308801A CN103772483A CN 103772483 A CN103772483 A CN 103772483A CN 201310308801 A CN201310308801 A CN 201310308801A CN 103772483 A CN103772483 A CN 103772483A
- Authority
- CN
- China
- Prior art keywords
- methylalanyl
- tryptophyl
- crystal
- phenmethyl
- ray
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Description
Claims (48)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58375704P | 2004-06-29 | 2004-06-29 | |
US60/583,757 | 2004-06-29 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800215163A Division CN1976921B (zh) | 2004-06-29 | 2005-06-22 | (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103772483A true CN103772483A (zh) | 2014-05-07 |
Family
ID=35064648
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310308801.XA Pending CN103772483A (zh) | 2004-06-29 | 2005-06-22 | (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 |
CN2005800215163A Active CN1976921B (zh) | 2004-06-29 | 2005-06-22 | (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 |
CN201110251236.9A Active CN102584937B (zh) | 2004-06-29 | 2005-06-22 | (3r)‑1‑(2‑甲基丙氨酰‑d‑色氨酰)‑3‑(苯甲基)‑3‑哌啶羧酸1,2,2‑三甲基酰肼的晶形 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800215163A Active CN1976921B (zh) | 2004-06-29 | 2005-06-22 | (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 |
CN201110251236.9A Active CN102584937B (zh) | 2004-06-29 | 2005-06-22 | (3r)‑1‑(2‑甲基丙氨酰‑d‑色氨酰)‑3‑(苯甲基)‑3‑哌啶羧酸1,2,2‑三甲基酰肼的晶形 |
Country Status (10)
Country | Link |
---|---|
US (2) | US7825138B2 (zh) |
EP (2) | EP1768976B1 (zh) |
JP (2) | JP5122950B2 (zh) |
KR (1) | KR101324340B1 (zh) |
CN (3) | CN103772483A (zh) |
CA (1) | CA2572325C (zh) |
HK (1) | HK1105000A1 (zh) |
IL (1) | IL180336A0 (zh) |
MX (1) | MXPA06015003A (zh) |
WO (1) | WO2006016995A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130281701A1 (en) | 2004-06-29 | 2013-10-24 | Helsinn Therapeutics (U.S.), Inc. | Crystal forms of anamorelin |
EP1768976B1 (en) * | 2004-06-29 | 2017-04-26 | Helsinn Healthcare S.A. | Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
JO3353B1 (ar) | 2012-04-20 | 2019-03-13 | Ono Pharmaceutical Co | شكل صلب معزول من أحادي هيدروكلوريد أناموريلين بنسبة مولارية منخفضة من الكلوريد: أناموريلين ومحتوى منخفض من مذيب عضوي متبقي |
PT2958916T (pt) * | 2013-02-21 | 2018-11-21 | Pfizer | Formas sólidas de um inibidor de cdk4/6 seletivo |
TN2017000040A1 (en) | 2014-09-04 | 2018-07-04 | Helsinn Healthcare Sa | Medical treatments based on anamorelin |
CN107001323A (zh) * | 2015-10-20 | 2017-08-01 | 江苏恒瑞医药股份有限公司 | 一种阿拉莫林的结晶形式及其制备方法 |
US9837965B1 (en) | 2016-09-16 | 2017-12-05 | Peregrine Semiconductor Corporation | Standby voltage condition for fast RF amplifier bias recovery |
CN115569119A (zh) | 2019-08-30 | 2023-01-06 | 赫尔森保健股份公司 | 具有改善稳定性的阿拉莫林片剂的生产方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6303620B1 (en) * | 1998-05-11 | 2001-10-16 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US20010041720A1 (en) * | 1999-11-10 | 2001-11-15 | Michael Ankersen | Compound with growth hormone releasing properties |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960705808A (ko) * | 1993-11-09 | 1996-11-08 | 조셉 에프. 디프리마 | 성장 호르몬의 방출을 촉진시키는 피페리딘, 피롤리딘 및 헥사하이드로-1H-아제핀(Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone) |
WO1998003473A1 (en) * | 1996-07-22 | 1998-01-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
HUP0100777A3 (en) * | 1998-01-16 | 2001-12-28 | Novo Nordisk As | Tripeptides with growth hormone releasing properties, pharmaceutical compositions comprising thereof and their use |
AU757217B2 (en) * | 1998-05-11 | 2003-02-06 | Helsinn Healthcare Sa | Compounds with growth hormone releasing properties |
ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
JP2007531769A (ja) * | 2004-03-30 | 2007-11-08 | サファイア セラピューティクス インコーポレイテッド | 成長ホルモン分泌促進薬を使用したc−反応性蛋白質の低減方法 |
EP1768976B1 (en) * | 2004-06-29 | 2017-04-26 | Helsinn Healthcare S.A. | Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
-
2005
- 2005-06-22 EP EP05766869.1A patent/EP1768976B1/en active Active
- 2005-06-22 CN CN201310308801.XA patent/CN103772483A/zh active Pending
- 2005-06-22 JP JP2007519301A patent/JP5122950B2/ja active Active
- 2005-06-22 MX MXPA06015003A patent/MXPA06015003A/es active IP Right Grant
- 2005-06-22 CN CN2005800215163A patent/CN1976921B/zh active Active
- 2005-06-22 WO PCT/US2005/022408 patent/WO2006016995A1/en active Application Filing
- 2005-06-22 CN CN201110251236.9A patent/CN102584937B/zh active Active
- 2005-06-22 US US11/165,598 patent/US7825138B2/en active Active
- 2005-06-22 EP EP10185517.9A patent/EP2298760B1/en active Active
- 2005-06-22 KR KR1020067026722A patent/KR101324340B1/ko active IP Right Grant
- 2005-06-22 CA CA2572325A patent/CA2572325C/en active Active
-
2006
- 2006-12-26 IL IL180336A patent/IL180336A0/en unknown
-
2007
- 2007-12-06 HK HK07113380.4A patent/HK1105000A1/xx unknown
-
2010
- 2010-07-06 US US12/831,009 patent/US8466173B2/en active Active
-
2012
- 2012-06-14 JP JP2012134975A patent/JP5718286B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6303620B1 (en) * | 1998-05-11 | 2001-10-16 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US20010041720A1 (en) * | 1999-11-10 | 2001-11-15 | Michael Ankersen | Compound with growth hormone releasing properties |
Also Published As
Publication number | Publication date |
---|---|
JP5122950B2 (ja) | 2013-01-16 |
MXPA06015003A (es) | 2007-08-07 |
EP2298760B1 (en) | 2015-08-05 |
CN1976921A (zh) | 2007-06-06 |
JP2008505078A (ja) | 2008-02-21 |
EP2298760A1 (en) | 2011-03-23 |
HK1105000A1 (zh) | 2008-02-01 |
US20070004638A1 (en) | 2007-01-04 |
CA2572325A1 (en) | 2006-02-16 |
KR20070030222A (ko) | 2007-03-15 |
CN1976921B (zh) | 2013-08-21 |
CA2572325C (en) | 2013-08-27 |
WO2006016995A1 (en) | 2006-02-16 |
EP1768976A1 (en) | 2007-04-04 |
JP5718286B2 (ja) | 2015-05-13 |
CN102584937B (zh) | 2017-03-01 |
US8466173B2 (en) | 2013-06-18 |
US7825138B2 (en) | 2010-11-02 |
CN102584937A (zh) | 2012-07-18 |
KR101324340B1 (ko) | 2013-10-31 |
JP2012188452A (ja) | 2012-10-04 |
US20110003996A1 (en) | 2011-01-06 |
IL180336A0 (en) | 2007-07-04 |
EP1768976B1 (en) | 2017-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1976921B (zh) | (3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形 | |
US10519120B2 (en) | Crystal modifications of elobixibat | |
CN102985423B (zh) | 嘌呤衍生物的结晶形式 | |
US5767124A (en) | Polymorphic forms of a growth hormone secretagogue | |
US11053224B2 (en) | Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof | |
EA025358B1 (ru) | N-(5S,6S,9R)-5-АМИНО-6-(2,3-ДИФТОРФЕНИЛ)-6,7,8,9-ТЕТРАГИДРО-5H-ЦИКЛОГЕПТА[b]ПИРИДИН-9-ИЛ-4-(2-ОКСО-2,3-ДИГИДРО-1H-ИМИДАЗО[4,5-b]ПИРИДИН-1-ИЛ)ПИПЕРИДИН-1-КАРБОКСИЛАТНАЯ СОЛЬ | |
KR20130023218A (ko) | 새로운 다형체 | |
CN110325536A (zh) | Janus激酶抑制剂的晶体形式 | |
WO2019056003A1 (en) | CO-CRYSTALS FROM NEFLAMAPIMOD (VX -745) | |
US9975921B2 (en) | Crystal forms of anamorelin | |
AU2005272074B2 (en) | Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide | |
KR20220087430A (ko) | N-tert-부틸-4[[2-(5-클로로-2-하이드록시-페닐)아세틸]아미노]피리딘-2-카르복사미드의 고체 형태 | |
WO1997015574A1 (en) | Polymorphic forms of a growth hormone secretagogue | |
WO2024006568A1 (en) | Salts of l-ergothioneine and crystalline forms thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1197827 Country of ref document: HK |
|
CB02 | Change of applicant information |
Address after: Lugano Switzerland / bazzero Applicant after: Heersen health care Co Ltd Address before: Lugano Switzerland / bazzero Applicant before: Helsinn Healthcare SA |
|
CB02 | Change of applicant information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140507 |
|
RJ01 | Rejection of invention patent application after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1197827 Country of ref document: HK |